
Idera Pharmaceuticals Announces $5.0 Million in Further Proceeds from Private Placement
EXTON, PA — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) announced the closing of a second tranche under its April 7, 2020, securities purchase agreement, resulting in aggregate proceeds of up to …
Read More